欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Outgoing Georgia Congressman Buddy Carter Eyed For FDA Commissioner

2026-08-19
Stock Watch: Pharma Reaches For Substitutes As Organic Growth Founders

2026-08-19
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews

2026-08-19
Lawsuit Paid And Patents Delisted Following Teva’s QVAR Inhaler Generics Settlement

2026-08-19
Biocon Announces U.S. FDA Approval for Yesintek® (ustekinumab-kfce) Single-dose Prefilled Autoinjector

2026-08-19
Strengthening public health across Lebanon with EIB Global

2026-08-18
Silence Lays Out Phase III Plans For Divesiran In Polycythemia Vera

2026-08-18
New leadership team appointments

2026-08-18
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

2026-08-18
Novo Nordisk and AWS form AI partnership to speed drug discovery

2026-08-18
Press release (on il Sole 24 Ore) – Interim Report First Half (as at 30 June 2026)

2026-08-17
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

2026-08-17